Detailed price information for Oncolytics Biotech Inc (ONCY-Q) from The Globe and Mail including charting and trades.

Oncolytics Biotech® Inc. (Nasdaq: ONCY) (TSX: ONC) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company ...

ONC:CA Company Profile Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments.

BeOne Medicines Ltd. (ONC) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings.

Oncolytics Biotech ®  Inc. (NASDAQ: ONCY) (TSX: ONC) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing pelareorep, today reported financial results and recent ...

BeiGene to Change Nasdaq Ticker Symbol to “ONC” on January 2; Present at 43rd Annual J.P. Morgan Healthcare Conference December 23, 2024 06:00 AM Eastern Standard Time ...

BeOne Medicines Ltd. (NASDAQ:ONC) also made strides in pipeline growth, advancing 13 new molecules into clinical trials in 2024 alone. With 170+ global trials and over 25,000 patients enrolled ...

BeOne Medicines Ltd. (NASDAQ:ONC) has unveiled new data from the pivotal Phase 3 SEQUOIA trial at the 2025 ASCO Annual Meeting, highlighting the strong efficacy of BRUKINSA (zanubrutinib) both as ...

ONC and the Sequoia Project want to give health information networks interested in participating in TEFCA at least 90 days to review materials and assess whether they plan to apply, Yeager said ...